NEW YORK, NY / ACCESSWIRE / September 22, 2020 / Grays Peak Capital, a Global Investment Firm, announced the successful listing of portfolio company, COMPASS Pathways plc. (COMPASS (CMPS)) on the NASDAQ stock exchange as of September 18, 2020. This marks the fourth portfolio company to successfully list on a public exchange.
COMPASS is considered a leader in the biotechnology space using synthetic production as a disruptor to the existing healthcare industry, one of the largest industries in the world. The company has received breakthrough therapy designation from the FDA for the treatment of treatment-resistant depression (TRD).
The company focuses on creating synthetic compounds to treat post-traumatic stress disorder and other mental health conditions. Using data science technology paired with existing therapies, they have streamlined the process and created a new category through this innovation.
"Grays Peak continues to invest in leading companies that are leveraging disruptive technology, data science, artificial intelligence, and cutting-edge scientific research. We continue to see industries being disrupted by new entrants who have differentiation in how they operate and take advantage of technology. Consumer and Biotech continues to be an area of focus and growth for the firm. " stated Scott Stevens, Founder of Grays Peak Capital.
About Grays Peak Capital
Grays Peak Capital (www.grayspeakcapital.com) is a global investment firm that manages assets focused on the public market, private equity, real estate and credit. The firm is focused on identifying emerging business trends and technologies across a variety of industries. The firm endeavors to invest in companies that are creating innovation and disruption within their respective industry. Our portfolio includes multinational brands that have created value by disrupting industries and embracing technology led innovation.
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Grays Peak Capital (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Grays Peak Capital